MedAssets (Nasdaq: MDAS) is expected to report Q2 earnings on July 31. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict MedAssets's revenues will grow 2.9% and EPS will wane -7.1%.

The average estimate for revenue is $167.8 million. On the bottom line, the average EPS estimate is $0.26.

Revenue details
 Last quarter, MedAssets reported revenue of $172.8 million. GAAP reported sales were 15% higher than the prior-year quarter's $149.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.41. GAAP EPS of $0.13 for Q1 were much higher than the prior-year quarter's $0.00 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 80.2%, 110 basis points better than the prior-year quarter. Operating margin was 19.1%, 710 basis points better than the prior-year quarter. Net margin was 4.5%, 470 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $679.1 million. The average EPS estimate is $1.29.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 65 members out of 79 rating the stock outperform, and 14 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give MedAssets a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MedAssets is outperform, with an average price target of $20.88.

Is MedAssets the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.